英特格拉生命科学(IART)今日盘前股价大跌5.44%,引发市场关注。主要原因如下:
首先,公司公布的第四季度营收4.426亿美元,低于分析师预期的4.451亿美元,财报营收数据不佳令投资者失望。虽然公司第四季度利润超出预期,但营收不佳引发了市场对其业绩的担忧。
其次,公司下调了2025年第一季度收入和利润预期。英特格拉预计第一季度收入在3.75亿美元至3.85亿美元,低于分析师预计的4.102亿美元;同时对第一季度每股利润预期也介于0.40美元至0.45美元,低于市场预期,这无疑加剧了市场对其未来发展前景的担忧。
再者,该股在过去12个月内下跌了50.7%,股价持续下跌期间任何不利消息都可能引发投资者进一步抛售。因此,公司业绩数据不佳和下调业绩预期,引发了投资者本轮抛售情绪。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.